Asymptomatic hemorrhage after thrombolysis may not be benign - Prognosis by hemorrhage type in the Canadian Alteplase for Stroke Effectiveness Study registry

被引:168
作者
Dzialowski, Imanuel
Pexman, J. H. Warwick
Barber, Philip A.
Demchuk, Andrew M.
Buchan, Alastair M.
Hill, Michael D.
机构
[1] Foothills Prov Gen Hosp, Dept Clin Neurosci, Calgary Stroke Program, Calgary, AB, Canada
[2] Univ Calgary, Dept Med, Dept Community Hlth Sci, Calgary, AB, Canada
[3] Univ Oxford, Dept Gerontol, Oxford, England
[4] Univ Dresden, Dept Neurol, Dresden, Germany
基金
英国医学研究理事会;
关键词
acute stroke; intracranial hemorrhage; thrombolysis; thrombolytic treatment;
D O I
10.1161/01.STR.0000251644.76546.62
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-There is ongoing controversy about the impact of hemorrhagic transformation after thrombolysis on long-term functional outcome. We sought to study the relation between the type of hemorrhagic transformation on CT scans and functional outcome. Methods-Data were obtained from the Canadian Alteplase for Stroke Effectiveness Study. This study was established as a registry to prospectively collect data for acute stroke patients receiving intravenous alteplase within 3 hours from stroke onset between February 1999 and June 2001. Follow-up was completed at 90 days, and good functional outcome was defined as a modified Rankin Scale score of 0 or 1. Copies of head CT scans obtained at 24 to 48 hours after starting treatment were read in consensus by a central reading panel consisting of 1 neuroradiologist and 1 stroke neurologist. According to European Cooperative Acute Stroke Study criteria, hemorrhagic transformation was classified as none, hemorrhagic infarction (HI-1 and HI-2), or parenchymal hematoma (PH-1 and PH-2). We compared outcome across Groups and performed a multivariable analysis including previously determined important predictors of good outcome in acute ischemic stroke. Results-From 1135 patients enrolled at 60 centers across Canada, 954 follow-up CT scans were assessable. We observed some hemorrhagic transformation in 259 of 954 (27.1%) patients (110 HI-1, 57 HI-2, 48 PH-1, and 44 PH-2). Proportions of patients with good outcome were 41% with no hemorrhagic transformation, 30% with HI-1, 17% with HI-2, 15% with PH-1, and 7% with PH-2 (P < 0.0001, X test). After adjustment for age, baseline serum glucose, baseline Alberta Stroke Program Early CT score, and baseline National Institutes of Health Stroke Scale score, HI-1 was not a predictor of outcome. However, HI-2 (odds ratio=0.38, 95% CI=0.17 to 0.83), PH-1 (odds ratio=0.32, 95% CI=0.12 to 0.80), and PH-2 (odds ratio=0.14, 95% CI=0.04 to 0.48) were all negative predictors of outcome. Conclusions-The likelihood of a poor outcome after thrombolysis was proportional to the extent of hemorrhage on CT scans. HI grades of hemorrhagic transformation may not be benign.
引用
收藏
页码:75 / 79
页数:5
相关论文
共 19 条
[1]  
Arnould MC, 2004, AM J NEURORADIOL, V25, P939
[2]   The probability of middle cerebral artery MRA flow signal abnormality with quantified CT ischaemic change: targets for future therapeutic studies [J].
Barber, PA ;
Demchuk, AM ;
Hill, MD ;
Pexman, JHW ;
Hudon, ME ;
Frayne, R ;
Buchan, AM .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2004, 75 (10) :1426-1430
[3]   Neurological deterioration in acute ischemic stroke -: Potential predictors and associated factors in the European Cooperative Acute Stroke Study (ECASS) I [J].
Dávalos, A ;
Toni, D ;
Iweins, F ;
Lesaffre, E ;
Bastianello, S ;
Castillo, J .
STROKE, 1999, 30 (12) :2631-2636
[4]   Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke [J].
Demchuk, AM ;
Morgenstern, LB ;
Krieger, DW ;
Chi, TL ;
Hu, W ;
Wein, TH ;
Hardy, RJ ;
Grotta, JC ;
Buchan, AM .
STROKE, 1999, 30 (01) :34-39
[5]   Extent of early ischemic changes on computed tomography (CT) before thrombolysis - Prognostic value of the Alberta Stroke Program Early CT Score in ECASS II [J].
Dzialowski, I ;
Hill, MD ;
Coutts, SB ;
Demchuk, AM ;
Kent, DM ;
Wunderlich, O ;
von Kummer, R .
STROKE, 2006, 37 (04) :973-978
[6]   Hemorrhagic transformation within 36 hours of a cerebral infarct - Relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort [J].
Fiorelli, M ;
Bastianello, S ;
von Kummer, R ;
del Zoppo, GJ ;
Larrue, V ;
Lesaffre, E ;
Ringleb, AP ;
Lorenzano, S ;
Manelfe, C ;
Bozzao, L .
STROKE, 1999, 30 (11) :2280-2284
[7]   Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) [J].
Hacke, W ;
Kaste, M ;
Fieschi, C ;
von Kummer, R ;
Davalos, A ;
Meier, D ;
Larrue, V ;
Bluhmki, E ;
Davis, S ;
Donnan, G ;
Schneider, D ;
Diez-Tejedor, E ;
Trouillas, P .
LANCET, 1998, 352 (9136) :1245-1251
[8]  
HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017
[9]  
Hacke W, 2004, LANCET, V363, P768
[10]   Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study [J].
Hill, MD ;
Buchan, AM .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2005, 172 (10) :1307-1312